The immunoassay analyzer uses a chemiluminescence method to determine the substance content according to the intensity of the radiant light produced by the chemical reaction. Chemiluminescence immunoassay is to combine the chemiluminescence system with the immune response, edit the antibody or antigen with chemiluminescence-related substances, and after reacting with the antigen or antibody to be tested, the free chemiluminescence label is separated and added to the chemiluminescence system Other related substances produce chemiluminescence for quantitative or qualitative detection of antigens or antibodies. Chemiluminescence immunoassay is a new generation of immunoassay technology following radioimmunoassay, enzyme-linked immunoassay, fluorescence immunoassay, and time-resolved immunoassay. He expanded the scope of immunoassays and made more and more test items. It has been used in thyroid, reproductive hormones, myocardial damage and tumor markers, infectious diseases, anemia, bone metabolism, etc.
The immunoassay analyzer can be used for tumor marker detection, thyroid function detection, endocrine hormone series, and infectious disease detection. Chemiluminescence immunoassay is currently recognized as an advanced labeling immunoassay technology in the world, with high accuracy and specificity, and has become one of the most important techniques in testing methods.
The immunoassay analyzer can be used to detect tumor, thyroid, endocrine and other chemical substances. Their presence or quantitative change can indicate the nature of the tumor, so as to understand the tumor’s tissue occurrence, cell differentiation, and cell function to help tumor diagnosis, classification, and prognosis Judgment and treatment guidance help patients find and treat early and reduce the prevalence.